We are live on ! Find out more
Xponance

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
Cap. Flow
+$1.58B
Cap. Flow %
11.22%
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5 years
Top 10 Avg Time Held
4.8 years
Top 20 Avg Time Held
3.7 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$110M
2
AAPL icon
Apple
AAPL
+$89M
3
MSFT icon
Microsoft
MSFT
+$81.1M
4
AMZN icon
Amazon
AMZN
+$54.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M

Sector Composition

Rank Sector Weight
1 Technology 35.95%
2 Financials 11.04%
3 Consumer Discretionary 10.62%
4 Communication Services 10.59%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KRMN icon
876
Karman Holdings
KRMN
$3.99B
$700K 0.01%
8,739
+1,083
+14% +$104K
2025 Q3
2 quarters
MTG icon
877
MGIC Investment
MTG
$5.6B
$699K 0.01%
26,647
+6,020
+29% +$161K
2020 Q4
21 quarters
GAP icon
878
The Gap Inc
GAP
$7.96B
$698K 0.01%
28,835
+7,373
+34% +$195K
2021 Q1
20 quarters
HR icon
879
Healthcare Realty
HR
$5.84B
$694K ﹤0.01%
40,835
+9,242
+29% +$162K
2022 Q3
14 quarters
DOCS icon
880
Doximity
DOCS
$5.33B
$690K ﹤0.01%
29,601
+3,335
+13% +$104K
2022 Q2
15 quarters
TNL icon
881
Travel + Leisure Co
TNL
$3.84B
$690K ﹤0.01%
9,968
+1,704
+21% +$123K
2020 Q2
23 quarters
SBRA icon
882
Sabra Healthcare REIT
SBRA
$4.9B
$689K ﹤0.01%
35,807
+5,860
+20% +$115K
2020 Q2
23 quarters
NVS icon
883
Novartis
NVS
$279B
$688K ﹤0.01%
4,507
+961
+27% +$147K
2024 Q2
7 quarters
CHE icon
884
Chemed
CHE
$6.71B
$687K ﹤0.01%
1,820
+396
+28% +$170K
2020 Q2
23 quarters
ESE icon
885
ESCO Technologies
ESE
$6.67B
$686K ﹤0.01%
2,437
+395
+19% +$99.6K
2024 Q3
6 quarters
AGX icon
886
Argan
AGX
$5.13B
$684K ﹤0.01%
1,256
+203
+19% +$82.8K
2025 Q2
3 quarters
ESAB icon
887
ESAB
ESAB
$4.01B
$683K ﹤0.01%
7,064
+1,637
+30% +$190K
2022 Q4
13 quarters
OLLI icon
888
Ollie's Bargain Outlet
OLLI
$5.53B
$682K ﹤0.01%
7,413
+1,742
+31% +$188K
2020 Q2
23 quarters
OZK icon
889
Bank OZK
OZK
$4.9B
$682K ﹤0.01%
14,862
+2,028
+16% +$95.5K
2020 Q2
23 quarters
NXST icon
890
Nexstar Media Group
NXST
$4.94B
$675K ﹤0.01%
3,734
+810
+28% +$182K
2022 Q4
13 quarters
WEX icon
891
WEX
WEX
$5.95B
$673K ﹤0.01%
4,399
+954
+28% +$149K
2020 Q2
23 quarters
MATX icon
892
Matsons
MATX
$7.04B
$670K ﹤0.01%
4,087
+1,313
+47% +$204K
2023 Q2
11 quarters
LSTR icon
893
Landstar System
LSTR
$5.74B
$665K ﹤0.01%
4,148
+948
+30% +$145K
2020 Q2
23 quarters
ETSY icon
894
Etsy
ETSY
$7.61B
$665K ﹤0.01%
13,302
+1,889
+17% +$103K
2020 Q2
23 quarters
W icon
895
Wayfair
W
$14.4B
$664K ﹤0.01%
8,825
+2,164
+32% +$196K
2025 Q2
3 quarters
PCVX icon
896
Vaxcyte
PCVX
$10.6B
$662K ﹤0.01%
11,398
+2,318
+26% +$126K
2023 Q2
11 quarters
EMN icon
897
Eastman Chemical
EMN
$7.19B
$662K ﹤0.01%
8,678
+2,990
+53% +$216K
2020 Q2
23 quarters
SMTC icon
898
Semtech
SMTC
$15B
$661K ﹤0.01%
8,600
+1,712
+25% +$141K
2024 Q3
6 quarters
CORT icon
899
Corcept Therapeutics
CORT
$12.6B
$661K ﹤0.01%
16,404
+1,922
+13% +$71.9K
2024 Q3
6 quarters
KNF icon
900
Knife River
KNF
$2.72B
$659K ﹤0.01%
8,077
+1,128
+16% +$90.9K
2023 Q2
11 quarters

Similar funds

Xponance's Q1 2026 Portfolio in Review

As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.

  • Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
  • Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
  • Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
  • Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
  • Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
  • Xponance opened 165 new positions and closed 49 in Q1 2026.
  • Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.